Literature DB >> 8734702

Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws.

C J Glueck1, R E McMahon, J Bouquot, D Stroop, T Tracy, P Wang, B Rabinovich.   

Abstract

OBJECTIVES: Our specific aim in 49 patients (42 women, 7 men) with osteonecrosis of the jaw was to determine whether thrombophilia (increased tendency to intravascular thrombosis) or hypofibrinolysis (reduced ability to lyse thrombi) were associated with this regional avascular necrosis. STUDY
DESIGN: Determinants of thrombosis and fibrinolysis were compared in healthy controls and in 42 women and 7 men who had biopsy-proven idiopathic osteonecrosis of the jaw with severe chronic jaw or facial pain syndromes and failure to respond to conventional medical and dental treatments.
RESULTS: Of the 49 patients, 35 (71%) had thrombophilia or hypofibrinolysis and only 14 were normal. Thrombophilia as a sole coagulation defect was found in 10 patients, 7 with resistance to activated protein C and 3 with low protein C (deficiency of an antithrombotic protein). Hypofibrinolysis with low stimulated tissue plasminogen activator activity and high lipoprotein (a) (an atherogenic, hypofibrinolytic lipoprotein) were found as sole coagulation defects in seven and eight patients, respectively. Ten patients had mixed defects; 7 of these 10 had thrombophilia with resistance to activated protein C. Sinusoidal dilatation was a constant feature in maxillary and mandibular bone biopsies, suggesting venous occlusion with intramedullary hypertension. Marrow fibrosis and occasional fibrin plugs were additional microscopic features believed to impair venous drainage and to contribute to ischemic necrosis of the alveolar bone.
CONCLUSIONS: Primary thrombophilia and hypofibrinolysis appear to be common, heritable, pathophysiologic risk factors for idiopathic osteonecrosis of the jaws. These coagulation defects may also contribute to alveolar neuralgia, atypical odontalgia and facial neuralgia, idiopathic trigeminal neuralgia, and to treatment failures so often encountered in patients with alveolar osteonecrosis and disabling chronic facial and jawbone pain syndromes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734702     DOI: 10.1016/s1079-2104(96)80047-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  5 in total

1.  Osteonecrosis in genetic disorders.

Authors:  Laura Masi; Alberto Falchetti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

Review 2.  Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors:  Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal:  Ann N Y Acad Sci       Date:  2011-02       Impact factor: 5.691

3.  Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13.

Authors:  Wei-Ming Chen; Yu-Fen Liu; Ming-Wei Lin; I-Chun Chen; Pei-Yu Lin; Guan-Lu Lin; Yuh-Shan Jou; Yang-Te Lin; Cathy S J Fann; Jer-Yuarn Wu; Kwang-Jen Hsiao; Shih-Feng Tsai
Journal:  Am J Hum Genet       Date:  2004-06-03       Impact factor: 11.025

4.  Osteonecrosis of the Jaw Beyond Bisphosphonates: Are There Any Unknown Local Risk Factors?

Authors:  Johann Lechner; Volker von Baehr; Bernd Zimmermann
Journal:  Clin Cosmet Investig Dent       Date:  2021-01-19

Review 5.  Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.

Authors:  Minerva Codruta Badescu; Elena Rezus; Manuela Ciocoiu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.